PMID- 36382640 OWN - NLM STAT- MEDLINE DCOM- 20231225 LR - 20231225 IS - 1423-0259 (Electronic) IS - 0030-3747 (Linking) VI - 66 IP - 1 DP - 2023 TI - Early Retinal Microvasculopathy in Prediabetic Patients and Correlated Factors. PG - 367-376 LID - 10.1159/000527957 [doi] AB - INTRODUCTION: We aimed to detect early retinal microcirculation changes in prediabetic patients and investigate their correlation with clinical examinations. METHODS: Forty-seven prediabetic individuals, 29 controls, and 81 type 2 diabetic mellitus (T2DM) patients were enrolled in this study. A review of clinical data and spectral-domain optical coherence tomography angiography (SD-OCTA) parameters of macular vessel diameter (VD), foveal avascular zone (FAZ), and macular vessel area density (VAD) was performed. RESULTS: Levels of low-density lipoprotein cholesterol and triglycerides in prediabetes and T2DM groups were significantly higher than those in the control group. The urine microalbumin-to-creatinine ratio (ACR) was mildly and moderately increased in the prediabetes and T2DM groups, respectively. The estimated glomerular filtration rate of the three groups was within the normal range. SD-OCTA showed that VAD in the superficial macular area was decreased in the prediabetes group compared to the control group (p = 0.01). The FAZ size, particularly in the deep layer, was expanded in the prediabetes group. In the deep retinal layer of the macular area, VD and FAZ size in the prediabetes group were larger than those in the control group. In the prediabetes group, the axial length was significantly correlated with macular VD and FAZ size (p < 0.05), and ACR was correlated with FAZ size (p < 0.05). Age had a negative correlation with VAD (p < 0.01). ACR had a positive correlation with FAZ size (p < 0.05). CONCLUSIONS: Enlargement and irregularity of the FAZ area, deep capillary dilation, and a decrease in VAD occur in the retina of prediabetic patients with mild kidney function impairment. CI - (c) 2022 The Author(s). Published by S. Karger AG, Basel. FAU - Xu, Yi AU - Xu Y AD - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital, Shanghai, China. AD - Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Fundus Diseases, Shanghai, China. FAU - Zhu, Xiaofeng AU - Zhu X AD - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital, Shanghai, China, carrie915@126.com. AD - Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, carrie915@126.com. AD - Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China, carrie915@126.com. AD - National Clinical Research Center for Eye Diseases, Shanghai, China, carrie915@126.com. AD - Shanghai Key Laboratory of Fundus Diseases, Shanghai, China, carrie915@126.com. FAU - Wang, Yongyi AU - Wang Y AD - Department of Medical Administration, Huizhou First Hospital, Huizhou, China. FAU - Chu, Zhongdi AU - Chu Z AD - Departments of Bioengineering and Ophthalmology, University of Washington, Seattle, Washington, USA. FAU - Wang, Ruikang K AU - Wang RK AD - Departments of Bioengineering and Ophthalmology, University of Washington, Seattle, Washington, USA. FAU - Lu, Lina AU - Lu L AD - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital, Shanghai, China. AD - Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Fundus Diseases, Shanghai, China. FAU - Zou, Haidong AU - Zou H AD - Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital, Shanghai, China. AD - Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. AD - Shanghai Engineering Research Center of Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Fundus Diseases, Shanghai, China. LA - eng PT - Journal Article PT - Review DEP - 20221116 PL - Switzerland TA - Ophthalmic Res JT - Ophthalmic research JID - 0267442 SB - IM MH - Humans MH - *Prediabetic State/complications/diagnosis MH - Fluorescein Angiography/methods MH - Retinal Vessels MH - Retrospective Studies MH - Retina MH - Tomography, Optical Coherence/methods MH - *Diabetes Mellitus, Type 2/complications/diagnosis OTO - NOTNLM OT - Estimated glomerular filtration rate OT - Optical coherence tomography angiography OT - Prediabetes OT - Urine microalbumin-creatinine ratio EDAT- 2022/11/17 06:00 MHDA- 2023/12/25 06:42 CRDT- 2022/11/16 05:53 PHST- 2022/06/18 00:00 [received] PHST- 2022/10/27 00:00 [accepted] PHST- 2023/12/25 06:42 [medline] PHST- 2022/11/17 06:00 [pubmed] PHST- 2022/11/16 05:53 [entrez] AID - 000527957 [pii] AID - 10.1159/000527957 [doi] PST - ppublish SO - Ophthalmic Res. 2023;66(1):367-376. doi: 10.1159/000527957. Epub 2022 Nov 16.